SMARCA4 and colorectal carcinoma: Additionally, elevated expression of PRMT1 or SMARCA4 in CRC patients were positively correlated with expression of EGFR and TNS4, and CRC patients had shorter overall survival, which is consistent with observations by Mathioudaki and co-workers [14].